ClinicalTrials.gg
Sign In
Status unknownNCT04363671AdoPro-Cov19Updated Apr 27, 2020

Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19)

An observational study in Remote Consultation and Covid-19, sponsored by Hôpital Cochin. Status unknown at 1 site in France. Open to participants aged 11 Years and older. Per ClinicalTrials.gov, last updated 2020-04-27.

Sponsored by Hôpital Cochin · Observational

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
11 Years and older
Sex
All
01

Study summary

The Maison des Adolescents (MDA) at Cochin Hospital (Paris) is a multidisciplinary service which welcomes adolescents in three different units: consultation, day care and hospitalization. However, the epidemic of coronavirus (COVID-19) in March 2020 which imposed the extreme limitation of contacts and then the confinement of the entire population, required urgent adaptation of care practices. Teleconsultation quickly became essential for most consultations (psychiatrists, psychologists, nurses, but also pediatricians and somatic physicians). In day hospital, daily reception could not be carried out, therapeutic workshops, family interviews, or speaking groups were organized remotely. In hospital unit, the interruption of visits required the organization of remote interviews with families. Far from the comfort of an organized and structured telepsychiatry, the use of videoconferencing was done in an emergency and without preparation. The objective is to explore the experience of adolescents, doctors and psychologists regarding emergency changes in the methods of their follow-up by setting up teleconsultation in the context of the COVID-19 epidemic.

Read the detailed description

The study will be monocentric, exploratory, and qualitative based on the Interpretative Phenomenological Analysis. 15 adolescents followed in consultation, day hospital or full hospitalization and 15 health professionals working at the Maison des Adolescents will be included. Semi-structured interviews will be carried out by a psychiatrist, based on flexible and evolving interview guides. Qualitative analysis of adolescents and therapists' interviews will allow to explore the experience of teleconsultation by each group of participants and to inform about the advantages and limits of a teleconsultation device in adolescent care.

02

Conditions studied

  • Remote Consultation
  • Covid-19

Keywords

  • Qualitative research
  • Adolescent
  • Health personnel attitude
  • Coronavirus
  • Quanrantine
03

In context

COVID-19

7,990 studies on the registry are indexed under COVID-19; 466 are open to participants now.

This study's planned enrollment of 30 is below the median of 268 across 3,208 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Hôpital Cochin is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

15 adolescents followed in consultation, day hospital or full hospitalization and 15 health professionals working at the MDA during the COVID-19 epidemic.

Eligibility criteria

Inclusion Criteria:

  • adolescents aged between 11 and 20 years who benefit from follow-up in the structure (at least two face-to-face consultations before setting up teleconsultations) and for whom their follow-up had to be changed urgently in the form of teleconsultation from March 2020 as part of the COVID-19 epidemic. Adolescents will be included in the various consultation, day hospitalization and full hospitalization units. The pathologies will be varied so as to cover different situations and experiences: eating disorders, mood disorders, personality disorders, anxiety disorders, or even chronic somatic illness.
  • health professionals working at the Maison des Adolescents at the time of the epidemic, from different specialties (psychiatrists, pediatricians, psychologists, nurses, etc.) and units (consultations, day hospitalization, full hospitalization).
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Exploration of themes emerging from analysis of the content of the interview with the adolescents and therapists

    To describe the experience of reorganization of care during the COVID-19 epidemic and acceptability of teleconsultation for the adolescents and the therapists.

    Time frame: six months

07

Study locations

1 site
  • Maison de Solenn, Cochin Hospital
    Paris, 75014, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2020; primary completion for Jun 2020, 1 month later.

Of 1,640 non-industry observational studies under COVID-19, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 30. This study's planned 1 month is below that.

Counting every sponsor, half of 1,774 studies reached it within 13 months; a quarter within 5 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2020
First posted
Apr 27, 2020
StartEst.
May 2020
Primary completionEst.
Jun 2020
CompletionEst.
Dec 2020
Last update
Apr 27, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04363671
Lead sponsor
Hôpital Cochin
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Responsible party
Carretier Emilie (MD Psychiatrist, Hôpital Cochin) — Principal investigator
First posted
Apr 27, 2020
Start date
May 2020 (estimated)
Primary completion
Jun 2020 (estimated)
Completion
Dec 2020 (estimated)
Last update
Apr 27, 2020

Study contacts

Emilie Carretier, MD
Contact
emilie.carretier@aphp.fr
+33 (0)158412814
Jonathan Lachal, PhD
Contact
jonathan.lachal@aphp.fr
+33 (0)158412814
Emilie Carretier, MD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19 →

Other studies from this sponsor

Hôpital Cochin

Start the discussion